Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)
Panagiota Economopoulou(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens), Evangelos Giotakis(National and Kapodistrian University of Athens), Μaria Anastasiou(National and Kapodistrian University of Athens), Μαρία Γκοτζαμανίδου(National and Kapodistrian University of Athens), George Kavourakis(National and Kapodistrian University of Athens), Evi Lianidou(Athens State University), Ioannis Kotsantis(National and Kapodistrian University of Athens), Pavlos Maragoudakis(National and Kapodistrian University of Athens), Αreti Strati(National and Kapodistrian University of Athens), Elena Vagia(Northwestern University), Constantine Prikas(University General Hospital Attikon), Eleni Gagari(Andreas Sygros Hospital), Nikolaos Papadimitriou(University General Hospital Attikon), Christos Perisanidis(National and Kapodistrian University of Athens), Efthymios Kirodimos(National and Kapodistrian University of Athens), George Koutsodontis(National and Kapodistrian University of Athens)
Cited by 16
Related Papers
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
The Landscape of Targeted Therapies in TNBC
|Cancers|2020|448
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.
|Head & Neck|2009|265
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
|Annals of Oncology|2022|148
Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells
|Molecular Cancer Research|2010|120